GUFIC BIOSCIENCES
|
GUFIC BIOSCIENCES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | |
|---|---|---|---|
| Profit Before Tax | ₹87 Cr | ₹94 Cr | ₹116 Cr |
| Adjustment | ₹65 Cr | ₹44 Cr | ₹34 Cr |
| Changes In working Capital | ₹-95 Cr | ₹7.44 Cr | ₹-130 Cr |
| Cash Flow after changes in Working Capital | ₹57 Cr | ₹145 Cr | ₹20 Cr |
| Cash Flow from Operating Activities | ₹45 Cr | ₹123 Cr | ₹-7.46 Cr |
| Cash Flow from Investing Activities | ₹-31 Cr | ₹-71 Cr | ₹-102 Cr |
| Cash Flow from Financing Activities | ₹32 Cr | ₹-37 Cr | ₹82 Cr |
| Net Cash Inflow / Outflow | ₹46 Cr | ₹15 Cr | ₹-27 Cr |
| Opening Cash & Cash Equivalents | ₹16 Cr | ₹1.14 Cr | ₹29 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹62 Cr | ₹16 Cr | ₹1.14 Cr |
Compare Cashflow Statement of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹4,253.7 Cr | -12.7% | 4.6% | 34.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -12.7% |
4.6% |
34.5% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses